Key Highlights
-
The market shifted to a positive trend on Monday.
-
News from a leading weight loss drug manufacturer fell short of investor expectations.
-
Top AI chip manufacturers continue to benefit from the AI boom.
With Thanksgiving approaching, investors were eager to express their gratitude a bit early. After a turbulent week, Wall Street showed signs of recovery on Monday, with many stocks—especially in tech—making notable gains. The Nasdaq Composite jumped nearly 3%, while both the Dow Jones Industrial Average and S&P 500 also saw solid increases.
|
Index Where to invest $1,000 now? Our analysts reveal top investment picks. Best 10 stocks to buy now. |
Daily Percentage Change |
Daily Point Change |
|---|---|---|
|
Dow |
+0.44% |
+203 |
|
S&P 500 |
+1.55% |
+102 |
|
Nasdaq |
+2.69% |
+599 |
Despite the upward trend, stocks fluctuated through the day. Here are some significant movers from Monday.
Stocks Seeing Gains Today
AVGO: +11%
Broadcom experienced a strong performance, largely driven by positive developments in the tech sector, which lifted the Nasdaq. Comments made over the weekend regarding Alphabet and its Google division bolstered confidence. With AI evolving, these developments favor Broadcom, a key chip supplier. Moreover, Amazon has unveiled plans to invest significantly in AI, which will likely benefit Broadcom’s chip business. Some investors, of course, might worry that this surge in AI spending could taper off eventually, but new announcements tend to overshadow such concerns.
OSCR: +22%
Oscar Health made significant gains as health insurance stocks surged following news of potential bipartisan support in Washington. After alarms were rung during the government shutdown regarding insurance subsidy extensions under the Affordable Care Act, recent announcements hinted at possible temporary extensions. This unexpected news sparked hope for Oscar’s shareholders, even though the company is still recovering from previous drops.
Stocks Facing Losses Today
NVO: -6%
Novo Nordisk faced a notable decline after disappointing results from a clinical trial aimed at Alzheimer’s treatment. Despite the CEO’s reassurances about the trial’s unpredictable nature, investors reacted negatively, especially given the ongoing struggles in finding effective treatments for this challenging condition.
ANF: -6%
Abercrombie & Fitch saw a 6% drop amid concerns as it prepares to release quarterly results. Investors are wary, expecting not just a quarterly decline but a weaker annual performance overall. Mixed signals about the holiday shopping season from various sources leave many uncertain. While some predict increased spending, others hint at potential belt-tightening due to inflation and job market instability. Abercrombie’s stock has plummeted by more than 50% this year.
Should You Invest $1,000 in Broadcom Right Now?
Before considering Broadcom, it might be worth looking into our analyst team’s suggestions. They have identified 10 stocks they believe offer great investment potential at this time, and oddly enough, Broadcom doesn’t make the cut. However, reflecting on past recommendations, an investment in Netflix back in 2004 would have multiplied by over 500 times, and Nvidia since 2005 has yielded impressive returns as well.
While the overall return averages of the recommendations stand at nearly 981%, compared to the S&P 500’s substantially lower rate, it might be beneficial to explore these top picks.
